Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.
Related products
-33%
Ceftriaxone Sodium
-18%
Ibn Sina Pharmaceuticals Ltd.
-19%
Flucloxacillin Sodium
-26%
Cefixime
-35%
Esomeprazole
-13%
Flucloxacillin Sodium
-13%
Esomeprazole
-22%
Domperidone Maleate